Related Experiment Video
Updated: Jul 6, 2026

Minimal Erythema Dose (MED) Testing
Published on: May 28, 2013
Erythema multiforme after use of topical dorzolamide
Vineeta Munshi1, Harpreet Ahluwalia
1Birmingham and Midland Eye Centre, Birmingham, United Kingdom. vineetamunshi@hotmail.com
Abstract:
Erythema multiforme may be a mild condition (erythema multiforme minor), or it may be a severe, possibly life-threatening condition (erythema multiforme major or Stevens-Johnson syndrome). Dorzolamide is a carbonic anhydrase inhibitor, which reduces intraocular pressure by suppressing aqueous production. In this paper we report on a patient who developed erythema multiforme following the use of topical dorzolamide.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Ophthalmic Drug Delivery Systems
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Allergic Drug Reactions
Toxidromes: Clinical Features
Hypersensitivity Reactions: Immune-Complex Reactions
